Format

Send to

Choose Destination
Am J Ophthalmol. 2011 Dec;152(6):982-8. doi: 10.1016/j.ajo.2011.05.015. Epub 2011 Aug 6.

A video study of drop instillation in both glaucoma and retina patients with visual impairment.

Author information

1
Glaucoma Specialists, Baltimore, Maryland, USA. hennessy.amy@gmail.com

Abstract

PURPOSE:

To compare self-administration of drops in both visually impaired glaucoma subjects and retina subjects.

DESIGN:

Prospective, observational study.

METHODS:

SETTING:

Distinct glaucoma and retina practices.

STUDY POPULATION:

Subjects with glaucoma or retinal diseases with visual acuity of 20/60 or worse in 1 eye, significant field loss, or both.

OBSERVATION PROCEDURES:

Subjects were video recorded self-instilling a drop onto the worse eye.

MAIN OUTCOME MEASURE:

Proper instillation of eye drop onto ocular surface.

RESULTS:

We included 409 subjects (205 glaucoma, 204 retina). Differences between the groups included the following: glaucoma subjects included fewer females (P = .05), included fewer white persons (P < .005), had worse visual acuity (P < .005), had less self-reported arthritis (P < .05), were younger (P < .005), and had more previous exposure to drop use (P < .005). Glaucoma subjects had more bilateral impairment (60% vs 42%; P < .0005). Retina subjects instilled more drops (1.7 vs 1.4; P = .02) and more frequently touched the bottle to the eye (47% vs 33%; P = .003). Of subjects claiming not to miss the eye, nearly one third from each group (P = .32) actually missed. Approximately one third of each group could not get a drop onto the eye (30% retina vs 29% glaucoma; P = .91). Among subjects placing 1 drop onto the eye without touching the adnexae, there was a trend for glaucoma patients to perform better, although both groups did poorly (success, 39% glaucoma vs 31% retina; P = .09).

CONCLUSIONS:

Among visually impaired subjects, regardless of cause, drop administration was a problem. Both groups wasted drops, contaminated bottles, and had inaccurate perception of their abilities. This has implications for future therapeutic delivery systems.

PMID:
21821228
DOI:
10.1016/j.ajo.2011.05.015
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center